BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Dendreon Strengthens Executive Team with Key Management Appointments

  Dendreon Pharmaceuticals today announced several key leadership appointments to further the company’s continued growth and expansion.

  October 26, 2017

   · 

  5 min read
• ENYO Pharma Opens a New Subsidiary in Australia as a New Managing Center for Clinical Trials

  Enyo Pharma made a strategic decision and has recently decided to open its first wholly owned subsidiary in Melbourne, Australia, because of its excellent clinical trials development capabilities and attractive conditions offered by the government.

  October 26, 2017

   · 

  2 min read
• Drug Development

  New Data Suggest Slowing of Cortical Gray Matter Atrophy with Sanofi Genzyme’s Aubagio (teriflunomide) is Associated with Delayed Conversion to Clinically Definite Multiple Sclerosis

  Sanofi Genzyme announced today new investigational data that suggest slowing of cortical gray matter volume loss (atrophy) with Aubagio (teriflunomide) is associated with delayed conversion to clinically definite multiple sclerosis.

  October 26, 2017

   · 

  9 min read
• Business

  Prism Research and MD Biosciences Receive First Contract Award as Members of the Minnesota Clinical Research Hub (MCRH)

  MCRH today announced its first contract for a multi-site, Phase I clinical research study.

  October 26, 2017

   · 

  2 min read
• Business

  Veracyte to Host Conference Call and Webcast to Discuss Third Quarter 2017 Financial Results on Monday, November 6, 2017

  Veracyte announced today that it will report its third quarter 2017 financial results after the close of market on Monday, November 6, 2017.

  October 26, 2017

   · 

  1 min read
• Lone Star Bio

  CorInnova Awarded Seminal Patent for Minimally Invasively-Delivered Soft Robotic Heart Device to Support Heart Function

  CorInnova announced today three milestone events: (1) the Company has received notice of allowance of a seminal patent to protect its intellectual property associated with the world’s first minimally invasively-delivered soft robotic heart device to support heart function.

  October 26, 2017

   · 

  6 min read
• Business

  PierianDx Names New Additions to Sales and Clinical Genomic Solutions Teams

  PierianDx announced today two key additions that will expand the organization’s reach into health systems and global markets while deepening clinical expertise.

  October 26, 2017

   · 

  3 min read
• 4WEB Medical Demonstrates Increased Subsidence Resistance for Lateral Spine Truss System Compared to Annular Implants

  4WEB Medical announced the results of a new study demonstrating reduced subsidence for its Lateral Spine Truss System as compared to annular interbody implant designs today at the annual meeting of the North American Spine Society.

  October 26, 2017

   · 

  2 min read
• Business

  Teligent, Inc. to Hold Conference Call for Third Quarter 2017 Results

  A conference call will be held at 4:30pm ET on Monday November 6, 2017 to discuss the 3rd quarter 2017 financial results and business update.

  October 26, 2017

   · 

  1 min read
• Genetown

  VBI Vaccines Prices Concurrent Public Offering and Registered Direct Offering for Aggregate Proceeds of $63.5M

  The pricing for the underwritten public offering was for a total number of 14,000,000 common shares for expected gross proceeds of US$42.7 million

  October 26, 2017

   · 

  5 min read